Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lumos Diagnostics Holdings Ltd. is set to raise A$10.0 million through an equity offer to fund clinical trials, product development, and sales initiatives, with new shares priced at a significant discount. Tenmile Ventures is poised to become the company’s largest shareholder by fully subscribing to and sub-underwriting the offer, alongside existing shareholder Ryder Capital. The offer is underwritten by Bell Potter Securities Limited and will lead to a trading halt until the institutional component is completed.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.